Chemours Co (CC)

Nov 2, 2026

The Chemours Company has introduced its Faizeon line of two-phase liquid cooling fluids designed for AI, high-performance computing, and high-density data centers. These fluids utilize phase change to efficiently remove heat from processors and server components, offering superior cooling performance compared to single-phase, water-based fluids. Chemours has also emphasized the fluids' reusability and potential to reduce water consumption in cooling systems.

Nov 2, 2026

Chemours has introduced a new line of Faizeon HFO-based two-phase cooling fluids designed for high-density data centers and AI servers. These fluids, including direct-to-chip and immersion options, are engineered for superior heat transfer, reduced energy consumption, and minimal water usage. The company confirmed that the portfolio includes various HFOs and HFO blends, with specific products identified based on their published specifications.

Oct 30, 2026

The Law Offices of Frank R. Cruz reminds investors of upcoming lead plaintiff deadlines in securities class action lawsuits against The Chemours Company (CC), Compass, Inc. (COMP), and Millrose Properties, Inc. (MRP). Investors in these companies who suffered losses are encouraged to contact the firm to learn about their legal rights and the process for seeking lead plaintiff appointment. The complaints allege that the respective companies made false and/or misleading statements and failed to disclose material information during their class periods.

Oct 27, 2026

Bronstein, Gewirtz & Grossman, LLC has announced a class action lawsuit against Chemours Company (NYSE: CC) and some of its officers, alleging violations of federal securities laws. The lawsuit claims Chemours materially overstated aftermarket demand for its Opteon products, leading to decreasing demand due to overselling in the previous fiscal year and making their 2026 financial guidance unreliable. Investors who purchased Chemours securities between February 20, 2026, and August 4, 2026, are encouraged to join the case and can request to be appointed as lead plaintiff by December 7, 2026.

Oct 27, 2026

A class action lawsuit has been filed against The Chemours Company (NYSE: CC) and its senior executives for securities fraud, following an 18.63% stock drop on August 5, 2026. The lawsuit alleges that Chemours misrepresented the strength of demand for its Opteon products, leading to an oversupplied market. Investors who purchased Chemours securities have until December 7, 2026, to seek appointment as lead plaintiff in the case.